Global Pets NSAIDs market growth is projected to reach  US$ 484 million in 2025 to US$ 691 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Global Pets NSAIDs Market Trends and Analysis 2025-31

The global Pets NSAIDs market size is predicted to grow from US$ 484 million in 2025 to US$ 691 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031. Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the bodys response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area. According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%. Infinity Market Research newest research report, the Pets NSAIDs Industry Forecast looks at past sales and reviews total world Pets NSAIDs sales in 2024, providing a comprehensive analysis by region and market sector of projected Pets NSAIDs sales for 2025 through 2031. With Pets NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pets NSAIDs industry. This Insight Report provides a comprehensive analysis of the global Pets NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pets NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pets NSAIDs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pets NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pets NSAIDs. This report presents a comprehensive overview, market shares, and growth opportunities of Pets NSAIDs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Injection Type &nbsp;&nbsp;&nbsp; Oral Type &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Pet Hospital &nbsp;&nbsp;&nbsp; Pet Shop &nbsp;&nbsp;&nbsp; Household Use This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; JandJ &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Septodont &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; PerioChip &nbsp;&nbsp;&nbsp; Mobic &nbsp;&nbsp;&nbsp; Rimadyl &nbsp;&nbsp;&nbsp; Vetprofen &nbsp;&nbsp;&nbsp; Novox Key Questions Addressed in this Report What is the 10-year outlook for the global Pets NSAIDs market? What factors are driving Pets NSAIDs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Pets NSAIDs market opportunities vary by end market size? How does Pets NSAIDs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Pets NSAIDs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Pets NSAIDs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Pets NSAIDs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Pets NSAIDs Segment by Type &nbsp;2.2.1 Injection Type &nbsp;2.2.2 Oral Type &nbsp;2.2.3 Others &nbsp;2.3 Pets NSAIDs Sales by Type &nbsp;2.3.1 Global Pets NSAIDs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Pets NSAIDs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Pets NSAIDs Sale Price by Type (2020-2025) &nbsp;2.4 Pets NSAIDs Segment by Application &nbsp;2.4.1 Pet Hospital &nbsp;2.4.2 Pet Shop &nbsp;2.4.3 Household Use &nbsp;2.5 Pets NSAIDs Sales by Application &nbsp;2.5.1 Global Pets NSAIDs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Pets NSAIDs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Pets NSAIDs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Pets NSAIDs Breakdown Data by Company &nbsp;3.1.1 Global Pets NSAIDs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Pets NSAIDs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Pets NSAIDs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Pets NSAIDs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Pets NSAIDs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Pets NSAIDs Sale Price by Company &nbsp;3.4 Key Manufacturers Pets NSAIDs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Pets NSAIDs Product Location Distribution &nbsp;3.4.2 Players Pets NSAIDs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Pets NSAIDs by Geographic Region &nbsp;4.1 World Historic Pets NSAIDs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Pets NSAIDs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Pets NSAIDs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Pets NSAIDs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Pets NSAIDs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Pets NSAIDs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Pets NSAIDs Sales Growth &nbsp;4.4 APAC Pets NSAIDs Sales Growth &nbsp;4.5 Europe Pets NSAIDs Sales Growth &nbsp;4.6 Middle East & Africa Pets NSAIDs Sales Growth 5 Americas &nbsp;5.1 Americas Pets NSAIDs Sales by Country &nbsp;5.1.1 Americas Pets NSAIDs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Pets NSAIDs Revenue by Country (2020-2025) &nbsp;5.2 Americas Pets NSAIDs Sales by Type (2020-2025) &nbsp;5.3 Americas Pets NSAIDs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Pets NSAIDs Sales by Region &nbsp;6.1.1 APAC Pets NSAIDs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Pets NSAIDs Revenue by Region (2020-2025) &nbsp;6.2 APAC Pets NSAIDs Sales by Type (2020-2025) &nbsp;6.3 APAC Pets NSAIDs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Pets NSAIDs by Country &nbsp;7.1.1 Europe Pets NSAIDs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Pets NSAIDs Revenue by Country (2020-2025) &nbsp;7.2 Europe Pets NSAIDs Sales by Type (2020-2025) &nbsp;7.3 Europe Pets NSAIDs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Pets NSAIDs by Country &nbsp;8.1.1 Middle East & Africa Pets NSAIDs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Pets NSAIDs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Pets NSAIDs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Pets NSAIDs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Pets NSAIDs &nbsp;10.3 Manufacturing Process Analysis of Pets NSAIDs &nbsp;10.4 Industry Chain Structure of Pets NSAIDs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Pets NSAIDs Distributors &nbsp;11.3 Pets NSAIDs Customer 12 World Forecast Review for Pets NSAIDs by Geographic Region &nbsp;12.1 Global Pets NSAIDs Market Size Forecast by Region &nbsp;12.1.1 Global Pets NSAIDs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Pets NSAIDs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Pets NSAIDs Forecast by Type (2026-2031) &nbsp;12.7 Global Pets NSAIDs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck Pets NSAIDs Product Portfolios and Specifications &nbsp;13.1.3 Merck Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Bayer &nbsp;13.2.1 Bayer Company Information &nbsp;13.2.2 Bayer Pets NSAIDs Product Portfolios and Specifications &nbsp;13.2.3 Bayer Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Bayer Main Business Overview &nbsp;13.2.5 Bayer Latest Developments &nbsp;13.3 JandJ &nbsp;13.3.1 JandJ Company Information &nbsp;13.3.2 JandJ Pets NSAIDs Product Portfolios and Specifications &nbsp;13.3.3 JandJ Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 JandJ Main Business Overview &nbsp;13.3.5 JandJ Latest Developments &nbsp;13.4 GSK &nbsp;13.4.1 GSK Company Information &nbsp;13.4.2 GSK Pets NSAIDs Product Portfolios and Specifications &nbsp;13.4.3 GSK Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 GSK Main Business Overview &nbsp;13.4.5 GSK Latest Developments &nbsp;13.5 Septodont &nbsp;13.5.1 Septodont Company Information &nbsp;13.5.2 Septodont Pets NSAIDs Product Portfolios and Specifications &nbsp;13.5.3 Septodont Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Septodont Main Business Overview &nbsp;13.5.5 Septodont Latest Developments &nbsp;13.6 Roche &nbsp;13.6.1 Roche Company Information &nbsp;13.6.2 Roche Pets NSAIDs Product Portfolios and Specifications &nbsp;13.6.3 Roche Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Roche Main Business Overview &nbsp;13.6.5 Roche Latest Developments &nbsp;13.7 PerioChip &nbsp;13.7.1 PerioChip Company Information &nbsp;13.7.2 PerioChip Pets NSAIDs Product Portfolios and Specifications &nbsp;13.7.3 PerioChip Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 PerioChip Main Business Overview &nbsp;13.7.5 PerioChip Latest Developments &nbsp;13.8 Mobic &nbsp;13.8.1 Mobic Company Information &nbsp;13.8.2 Mobic Pets NSAIDs Product Portfolios and Specifications &nbsp;13.8.3 Mobic Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Mobic Main Business Overview &nbsp;13.8.5 Mobic Latest Developments &nbsp;13.9 Rimadyl &nbsp;13.9.1 Rimadyl Company Information &nbsp;13.9.2 Rimadyl Pets NSAIDs Product Portfolios and Specifications &nbsp;13.9.3 Rimadyl Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Rimadyl Main Business Overview &nbsp;13.9.5 Rimadyl Latest Developments &nbsp;13.10 Vetprofen &nbsp;13.10.1 Vetprofen Company Information &nbsp;13.10.2 Vetprofen Pets NSAIDs Product Portfolios and Specifications &nbsp;13.10.3 Vetprofen Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Vetprofen Main Business Overview &nbsp;13.10.5 Vetprofen Latest Developments &nbsp;13.11 Novox &nbsp;13.11.1 Novox Company Information &nbsp;13.11.2 Novox Pets NSAIDs Product Portfolios and Specifications &nbsp;13.11.3 Novox Pets NSAIDs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Novox Main Business Overview &nbsp;13.11.5 Novox Latest Developments 14 Research Findings and Conclusion

Report	Global Pets NSAIDs Market Growth 2025-2031
Selected License	Multi ID: LPI13796

Buyer Information

Order Summary